El País in English56m
Obesity surgery in the time of Ozempic: ‘They are not two competing treatments, but rather complementary ones’
Research reports that in the United States, the number of patients who underwent bariatric procedure decreased by 25%, while ...
MedPage Today53m
ADA Advises Against Compounded GLP-1s; Growth Hormone Therapy Guide; T1D Outcomes Up
The American Diabetes Association (ADA) urged healthcare providers against prescribing non-FDA approved compounded GLP-1 and ...